Anti-fibrotic actions of relaxin (vol 174, pg 962, 2017)

被引:0
|
作者
Samuel, C. S.
Royce, S. G.
Hewitson, T. D.
Denton, K. M.
Cooney, T. E.
Bennett, R. G.
机构
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:4836 / 4836
页数:1
相关论文
共 50 条
  • [31] Identification of cromolyn sodium as an anti-fibrotic agent targeting both hepatocytes and hepatic stellate cells (vol 102, pg 176, 2015)
    Choi, Joon-Seok
    Kim, Jun Ki
    Yang, Yoon Jung
    Kim, Yeseul
    Kim, Pilhan
    Park, Sang Gyu
    Cho, Eun-Young
    Lee, Dae Ho
    Choi, Jin Woo
    [J]. PHARMACOLOGICAL RESEARCH, 2016, 110 : 277 - 278
  • [32] RETRACTED: Anti-fibrotic actions of Ghrelin by inhibition of the NADPH oxidase-ROS signaling pathway (Retracted Article)
    Wang, Qian
    Sui, Xin
    Chen, Rui
    Ma, Peiyong
    Ding, Tao
    Sui, Dianjun
    Yang, Ping
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2018, 45 (08)
  • [33] Chronic lower-dose relaxin administration protects from arrhythmia in experimental myocardial infarction due to anti-inflammatory and anti-fibrotic properties
    Beiert, Thomas
    Knappe, Vincent
    Tiyerili, Vedat
    Stoeckigt, Florian
    Effelsberg, Verena
    Linhart, Markus
    Steinmetz, Martin
    Klein, Sabine
    Schierwagen, Robert
    Trebicka, Jonel
    Roell, Wilhelm
    Nickenig, Georg
    Schrickel, Jan W.
    Andrie, Rene P.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 250 : 21 - 28
  • [34] ALTERED EXPRESSION OF RELAXIN RECEPTOR RXFP1/LGR7 IN DERMAL FIBROBLASTS CONTRIBUTES TO THE INEFFICACY OF RELAXIN-BASED ANTI-FIBROTIC TREATMENTS IN SYSTEMIC SCLEROSIS
    Corallo, C.
    Cutolo, M.
    Soldano, S.
    Cheleschi, S.
    Fioravanti, A.
    Pinto, A. M.
    Renieri, A.
    Nuti, R.
    Giordano, N.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1279 - 1279
  • [35] Relaxin Can Mediate Its Anti-Fibrotic Effects by Targeting the Myofibroblast NLRP3 Inflammasome at the Level of Caspase-1
    Pinar, Anita A.
    Yuferov, Alexander
    Gaspari, Tracey A.
    Samuel, Chrishan S.
    [J]. FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [36] The descriptive content of names as predicate modifiers (vol 174, pg 2329, 2017)
    Poller, Olga
    [J]. PHILOSOPHICAL STUDIES, 2017, 174 (09) : 2361 - 2361
  • [37] Genetic Risk Variants for Social Anxiety (vol 174, pg 120, 2017)
    Stein, Murray B.
    Chen, Chia-Yen
    Jain, Sonia
    Jensen, Kevin P.
    He, Feng
    Heeringa, Steven G.
    Kessler, Ronald C.
    Maihofer, Adam
    Nock, Matthew K.
    Ripke, Stephan
    Sun, Xiaoying
    Thomas, Michael L.
    Ursano, Robert J.
    Smoller, Jordan W.
    Gelernter, Joel
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2017, 174 (04) : 470 - 482
  • [38] Go Figure: understanding figurative talk (vol 174, pg 1, 2017)
    Popa-Wyatt, Mihaela
    [J]. PHILOSOPHICAL STUDIES, 2017, 174 (05) : 1363 - 1363
  • [39] Relaxin Inhibits the Cardiac Myofibroblast NLRP3 Inflammasome as Part of Its Anti-Fibrotic Actions via the Angiotensin Type 2 and ATP (P2X7) Receptors
    Caceres, Felipe Tapia
    Gaspari, Tracey A.
    Hossain, Mohammed Akhter
    Samuel, Chrishan S.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [40] Factor VII activating protease (FSAP) exerts anti-inflammatory and anti-fibrotic effects in liver fibrosis in mice and men (vol 58, pg 104, 2013)
    Borkham-Kamphorst, Erawan
    Zimmermann, Henning W.
    Gassler, Nikolaus
    Bissels, Ute
    Bosio, Andreas
    Tacke, Frank
    Weiskirchen, Ralf
    Kanse, Sandip M.
    [J]. JOURNAL OF HEPATOLOGY, 2014, 61 (04) : 967 - 967